Pharming Group revenue and financials

PHARM · Euronext Amsterdam · EUR

Compare Pharming Group
€1.12Change from previous close: −1.97%Absolute change: −€0.02

Close · November 17, 2026

In the fiscal year ended December 2025, Pharming Group reported revenue of $376.13M (+26.56% year over year). Net income was $2.85M, a net margin of 0.8%.

Annual revenue · 2025: $376.13M
  1. $16.69M2016
  2. $107.51M2017
  3. $154.98M2018
  4. $189.39M2019
  5. $212.17M2020
  6. $198.87M2021
  7. $205.62M2022
  8. $245.32M2023
  9. $297.2M2024
  10. $376.13M2025

Fiscal year ending in December. Sources and method on the page How we analyse stocks.

At a glance

Revenue growth
+26.56%
2025 vs 2024
Net margin
0.8%
2024: -4.0%

How Pharming Group is changing

Calculated from the annual statements; each fiscal year is labelled with the year it ends.

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Income statement · Annual
Item2025202420232022202120202019201820172016
Total revenue37629724520619921218915510816.7
Cost of revenue45.535.425.217.621.123.523.925.414.94.9
Gross profit33126222018817818916513092.611.8
Selling, general and administrative20218417512791.075.765.953.644.98.1
Research and development98.283.168.752.565.438.532.633.122.416.2
Operating income32.8-3.6-21.810.424.076.367.443.626.3-12.1
EBIT32.8-3.6-21.810.424.076.367.443.626.3-12.1
EBITDA39.63.2-15.317.130.482.572.448.030.3-11.4
Interest expense10.78.76.05.46.15.913.416.422.43.8
Pre-tax income12.8-8.5-12.015.023.144.152.31.0-103-18.4
Income tax10.33.3-1.51.37.16.311.7-27.7-11.3—
Net income2.9-11.8-10.513.716.037.740.628.7-91.5-18.4
Net income to common shareholders2.9-11.8-10.513.716.037.740.628.7-91.5-18.4
Basic EPS0.00-0.02-0.020.020.020.060.060.05-0.18-0.04
Diluted EPS0.00-0.02-0.020.020.020.050.060.04-0.18-0.04
Average shares (basic)689671657649642636626607500415
Average shares (diluted)747671657707701683674654500415

Companies in the group: same industry, similar size